Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1652726

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Carers: Government Assistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help support unpaid carers with increases in the cost of living.
tabling member constituency	Leicester East
tabling member printed	Claudia Webbe
uin	193962
answer	answer is ministerial correction date of answer 24/07/2023 answer text <p>The Government recognises that the rising cost of living has presented additional financial challenges for many people, including unpaid carers.</p><p> </p><p>The Government continues to provide financial support to unpaid carers through Carer’s Allowance, the Carer Element in Universal Credit and through other benefits.</p><p>Unpaid carers in receipt of eligible benefits may receive additional support through the new Cost of Living Payments in 2023-24. These will help more than eight million United Kingdom households on eligible means tested benefits, eight million pensioner households and six million people across the UK on eligible disability benefits.</p><p>We want unpaid carers to live healthy and fulfilling lives alongside their caring role. This is why this Government is fully committed to the 10-year vision for Adult Social Care that we re-affirmed in the Next Steps to put People at the Heart of Care (2023).</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 24/07/2023 16:28:37 answering member 4527 label Biography information for Helen Whately
tabling member	4848 label Biography information for Claudia Webbe

1652761

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Disclosure of Information
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that staff in his Department who are under investigation for alleged misconduct are not named before those allegations are proven.
tabling member constituency	Solihull
tabling member printed	Julian Knight
uin	193906
answer	answer is ministerial correction date of answer 20/07/2023 answer text <p>The Department's policies follow Civil Service HR's wider model discipline policy. This makes clear that all disciplinary matters are strictly confidential, with all parties pertaining to an investigation process required to always maintain confidentiality, including once the process has concluded.</p><p>This sits alongside a separate 'raising a concern' policy, which is sometimes referred to as whistleblowing, in line with the Public Interest Disclosure Act 1998.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/07/2023 16:58:43 answering member 4423 label Biography information for Will Quince
tabling member	4410 label Biography information for Julian Knight

1652790

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to create stop vaping programmes for (a) adults and (b) children and young people.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	193921
answer	answer is ministerial correction date of answer 24/07/2023 answer text <p>As part of the national Swap to Stop scheme, we will be developing a stop vaping programme to help support adult vapers to be nicotine free. This component of the programme will be commissioned later this year.</p><p>Local stop smoking services can also provide resources to support children and adult vapers to quit, through funding from the public health grant.</p><p>We also launched a call for evidence to identify opportunities to reduce the number of under 18s accessing and using vape products. The call for evidence has now closed, and the government will be considering a range of options based on the evidence provided.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 193922 question first answered 24/07/2023 15:00:42 answering member 4679 label Biography information for Neil O'Brien
tabling member	4471 label Biography information for Rachael Maskell

1652791

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will provide additional resources to local public health teams to support stop vaping programmes.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	193922
answer	answer is ministerial correction date of answer 24/07/2023 answer text <p>As part of the national Swap to Stop scheme, we will be developing a stop vaping programme to help support adult vapers to be nicotine free. This component of the programme will be commissioned later this year.</p><p>Local stop smoking services can also provide resources to support children and adult vapers to quit, through funding from the public health grant.</p><p>We also launched a call for evidence to identify opportunities to reduce the number of under 18s accessing and using vape products. The call for evidence has now closed, and the government will be considering a range of options based on the evidence provided.</p> answering member constituency Harborough answering member printed Neil O'Brien grouped question UIN 193921 question first answered 24/07/2023 15:00:43 answering member 4679 label Biography information for Neil O'Brien
tabling member	4471 label Biography information for Rachael Maskell

1652792

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes: Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that public health messages on vaping are targeted at adults.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	193923
answer	answer is ministerial correction date of answer 24/07/2023 answer text <p>The Government’s public health messaging on vaping is clear, that vapes should only be recommended to support adult smokers quitting. They are not recommended for under-18s or non-smokers.</p><p>For example, on the Better Health website, we state that: “While vaping can help smokers quit, it is not harmless and is not for young people under 18. It is especially important to protect young lungs and brains.” The full page can be viewed at the following link:</p><p><a href="https://www.nhs.uk/better-health/quit-smoking/vaping-to-quit-smoking/" target="_blank">https://www.nhs.uk/better-health/quit-smoking/vaping-to-quit-smoking/</a></p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 24/07/2023 15:08:17 answering member 4679 label Biography information for Neil O'Brien
tabling member	4471 label Biography information for Rachael Maskell

1653013

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Home Care Services: Standards
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what are the Key Performance Indicators for homecare providers; and what is the actual level of performance against those indicators for each homecare provider, for the latest period for which data are available.
tabling member printed	Lord Blencathra
uin	HL9312
answer	answer is ministerial correction date of answer 26/07/2023 answer text <p>Appendix 10 of the 2014 Royal Pharmaceutical Society handbook contains the Key Performance Indicators for Homecare Medicine service providers. A copy is attached.</p><p>Providers of Homecare Medicines services operate in a highly regulated environment with obligations to record and monitor quality metrics, including any trends. To monitor industry trends, providers provide the same data set to the trade association, the National Clinical Homecare Association (NCHA), allowing for the aggregation of all providers metrics. The NCHA report that the delivery performance of providers (delivery to patients on the agreed date) was 99.0% in 2020, 98.6% in 2021 and 98.8% in 2022. Formal complaints and incidents are also monitored and the data shows that the percentage of complaints raised was 1.4% in 2020, 1.6% in 2021 and 1.8% in 2022 of active patients. This refers to complaints opened, not upheld.</p> answering member printed Lord Markham question first answered 26/07/2023 13:33:00 answering member 4948 label Biography information for Lord Markham attachment 1 file name 2014 - RPS Homecare Medicines Hanbook - Appendix 10 KPIs - 20-12-22 (1).xlsx title Attachment
tabling member	497 label Biography information for Lord Blencathra

1653014

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Home Care Services: Prescriptions
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government how many NHS hospitals have issued prescriptions to homecare providers (1) 10 or more days before the delivery is due, (2) between 10 days and the delivery date, and (3) after the delivery was supposed to be made.
tabling member printed	Lord Blencathra
uin	HL9313
answer	answer is ministerial correction date of answer 26/07/2023 answer text <p>This information is not collected centrally by NHS England or the Department. Each individual trust may or may not collect this data depending on the contracted Key Performance Indicators.</p> answering member printed Lord Markham question first answered 26/07/2023 13:33:11 answering member 4948 label Biography information for Lord Markham
tabling member	497 label Biography information for Lord Blencathra

1653015

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government whether Market Authorisation Holders set different (1) Key Performance Indicator measurements, and (2) clinical pathways, for the same therapy.
tabling member printed	Lord Blencathra
uin	HL9314
answer	answer is ministerial correction date of answer 26/07/2023 answer text <p>Marketing Authorisation Holders (MAHs) are encouraged to use the national Key Performance Indicators (KPIs) published in the Royal Pharmaceutical Homecare Services Handbook 2014 in their contracts with homecare providers. MAHs may also use additional or alternative specific KPIs where they consider this necessary. Neither NHS England nor National Health Service trusts are directly party to those contracts between MAHs and homecare providers, and therefore do not have visibility of the KPIs agreed in each case.</p><p>The treatment choice is determined by the clinician in the hospital trust in conversation with the patient, based on the best available evidence and cost-effectiveness aligned to national and local guidance where available. The homecare medicines service provider is contracted to undertake supply and delivery, and administration in some cases. The homecare medicines service provider does not determine the clinical pathway.</p> answering member printed Lord Markham question first answered 26/07/2023 13:33:48 answering member 4948 label Biography information for Lord Markham
tabling member	497 label Biography information for Lord Blencathra

1653026

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials: Rare Cancers
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what discussions they have had with European health ministers regarding working together to capture data from clinical trials for less common cancers, such as brain tumours.
tabling member printed	Lord Hunt of Kings Heath
uin	HL9327
answer	answer is ministerial correction date of answer 02/08/2023 answer text <p>Following the United Kingdom’s departure from the European Union, the Medicines and Healthcare products Regulatory Agency has not had recent discussions with European health ministers regarding collaboration to capture data from clinical trials for less common cancers, such as brain tumours.</p> answering member printed Lord Markham question first answered 02/08/2023 12:11:27 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1653028

registered interest
date	13/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what steps they are taking to ensure that more cancer drugs can transition from a Phase 1 study to Medicines and Healthcare products Regulatory Agency (MHRA) approval.
tabling member printed	Lord Hunt of Kings Heath
uin	HL9329
answer	answer is ministerial correction date of answer 20/07/2023 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is aware that customers who have submitted initial applications and amendments to our Clinical Investigations and Trials team have experienced extended timeframes in some cases, and understands how this unpredictability may be reducing the number of cancer drugs that can transition from a Phase 1 study to MHRA approval. To help improve the predictability of decision making in applications for clinical trials, the MHRA have implemented several actions.</p><p>The MHRA are looking at novel ways to develop staff capability and expertise. New assessor capacity is being supplemented with an additional fixed-term resource of appropriately experienced and qualified specialists to support the training and supervision of new staff and to help reduce the current backlog. The MHRA has also established links with the Association of the British Pharmaceutical Industry and the BioIndustry Association on clinical trials, to reduce the backlog of delayed applications, which may include applications for cancer drugs. Additionally, they have already reallocated work, and are evaluating queued applications for complexity, to improve the speed of assessment, and are changing processes to take a joined-up risk-proportionate approach.</p><p>The MHRA is committed to reducing these backlogs so that it makes regulatory decisions in accordance with statutory timeframes for all new fully compliant clinical trial applications received from 1 September 2023. This will enable more cancer drugs to progress from Phase 1 studies to MHRA approval where appropriate.</p> answering member printed Lord Markham question first answered 20/07/2023 16:33:27 answering member 4948 label Biography information for Lord Markham
tabling member	2024 label Biography information for Lord Hunt of Kings Heath